• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3ZZ*FX25RECA
Device Problem Use of Device Problem (1670)
Patient Problem Blood Loss (2597)
Event Date 09/13/2017
Event Type  Injury  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass for aortic dissection, the oxygenator failed.The partial pressure of oxygen (po2) kept on dropping drastically while rewarming the patient.There was minimal blood loss.Two (2) units of blood was given to the patient.Procedure was completed successfully.The patient was on circulatory arrest for ~25 minutes during which time the blood in the oxygenator was being recirculated at ~1.0 lpm through a bypass line and manifold line.Upon rewarming, the po2 decreased and the pco2 increased (this was approximately 45-60 minutes before weaning off bypass).A co2 flush was being used at the sterile field and then stopped, but the pco2 did not correspondingly decrease.They increased the fio2 to 100% and sweep gas to 10 lpm.At that point, the act was ~394 seconds so 10,000 units of heparin was given.Prior to that, all act values were >500 seconds.The oxygen line was connected directly to an oxygen cylinder and delivered 100% o2, but it did not make a difference.The patient received 2 units of prbc and ventilation.This allowed the patient to wean off bypass without having to change out the oxygenator.The po2 then increased to ~500 mmhg.The blood was administered about the same time as the ventilation.It is uncertain if the blood made a significant difference, the ventilating or a combination of both mitigation attempts.The patient¿s hematocrit never dropped below 22% and was 24-25% most of the case.No clots were noticed in the circuit at anytime.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda.(b)(4).The sample was returned for evaluation; however, we could not confirm the infectious nature of the device; therefore, the device was not used.A retention sample whose fiber lot number is the same as that of the report lot number was obtained.Visual inspection did not find any anomalies, such as break, which would relate to insufficient gas transfer performance.The sample was tested for its gas transfer performance, no anomalies were revealed and the obtained values met the factory specifications.A definitive root cause could not be determined; therefore, this complaint is not confirmed.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NS FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer Contact
cathleen hargreaves
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key6914138
MDR Text Key88164146
Report Number1124841-2017-00201
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/08/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/04/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Model Number3ZZ*FX25RECA
Device Catalogue NumberN/A
Device Lot NumberVF29
Other Device ID NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received12/08/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/31/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age40 YR
-
-